Search

Marcela M. Cordero Garcia

Examiner (ID: 4537)

Most Active Art Unit
1658
Art Unit(s)
1654, 1676, 1658
Total Applications
1421
Issued Applications
950
Pending Applications
83
Abandoned Applications
394

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11956082 [patent_doc_number] => 20170260232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE' [patent_app_type] => utility [patent_app_number] => 15/602156 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 28688 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602156 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/602156
TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE May 22, 2017 Abandoned
Array ( [id] => 12259411 [patent_doc_number] => 20180078606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS' [patent_app_type] => utility [patent_app_number] => 15/585320 [patent_app_country] => US [patent_app_date] => 2017-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6018 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585320 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/585320
METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS May 2, 2017 Abandoned
Array ( [id] => 14342161 [patent_doc_number] => 20190153053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT) [patent_app_type] => utility [patent_app_number] => 16/097582 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097582 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097582
PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT) Apr 27, 2017 Abandoned
Array ( [id] => 15365989 [patent_doc_number] => 20200018759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => DIAGNOSTIC METHOD OF LIVER CANCER USING ALPHA-FETOPROTEIN DERIVED GLYCOPEPTIDES BY MASS SPECTROMETRY [patent_app_type] => utility [patent_app_number] => 15/545552 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545552 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/545552
Diagnostic method of liver cancer using a-fetoprotein derived glycopeptides by mass spectrometry Apr 26, 2017 Issued
Array ( [id] => 11992474 [patent_doc_number] => 20170296628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'PEGYLATED BIOACTIVE PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/490618 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12539 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490618 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/490618
Pegylated bioactive peptides and uses thereof Apr 17, 2017 Issued
Array ( [id] => 12464481 [patent_doc_number] => 09986733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-05 [patent_title] => Compositions and methods for reducing ice crystal formation [patent_app_type] => utility [patent_app_number] => 15/486522 [patent_app_country] => US [patent_app_date] => 2017-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 27 [patent_no_of_words] => 22893 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486522 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/486522
Compositions and methods for reducing ice crystal formation Apr 12, 2017 Issued
Array ( [id] => 11757287 [patent_doc_number] => 20170204155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'PEPTIDE ANTAGONISTS OF THE CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/478053 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18743 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478053 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/478053
Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use Apr 2, 2017 Issued
Array ( [id] => 16984556 [patent_doc_number] => 11071706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-27 [patent_title] => Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium [patent_app_type] => utility [patent_app_number] => 16/089510 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5394 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089510 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/089510
Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium Mar 30, 2017 Issued
Array ( [id] => 11823185 [patent_doc_number] => 20170212120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'SELECTED REACTION MONITORING ASSAYS' [patent_app_type] => utility [patent_app_number] => 15/476118 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17536 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476118 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/476118
Selected reaction monitoring assays Mar 30, 2017 Issued
Array ( [id] => 13968305 [patent_doc_number] => 10213486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Formulations of diluted amino acid segments and methods for making same [patent_app_type] => utility [patent_app_number] => 15/470239 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13877 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470239 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470239
Formulations of diluted amino acid segments and methods for making same Mar 26, 2017 Issued
Array ( [id] => 11971196 [patent_doc_number] => 20170275350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods' [patent_app_type] => utility [patent_app_number] => 15/470117 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21123 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470117 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470117
Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods Mar 26, 2017 Issued
Array ( [id] => 11742866 [patent_doc_number] => 20170196938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES' [patent_app_type] => utility [patent_app_number] => 15/470169 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14465 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470169 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470169
Carrier-free biologically-active protein nanostructures Mar 26, 2017 Issued
Array ( [id] => 11727955 [patent_doc_number] => 20170189398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/467867 [patent_app_country] => US [patent_app_date] => 2017-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12396 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467867 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/467867
Methods and compositions for sleep disorders and other disorders Mar 22, 2017 Issued
Array ( [id] => 14145463 [patent_doc_number] => 10253090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Hydrolyzed collagen compositions and methods of making thereof [patent_app_type] => utility [patent_app_number] => 15/569240 [patent_app_country] => US [patent_app_date] => 2017-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4979 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569240 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569240
Hydrolyzed collagen compositions and methods of making thereof Mar 19, 2017 Issued
Array ( [id] => 11977619 [patent_doc_number] => 20170281774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'LINACLOTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/461923 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14671 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461923 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/461923
LINACLOTIDE COMPOSITIONS Mar 16, 2017 Abandoned
Array ( [id] => 16596726 [patent_doc_number] => 20210023257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => CEREBROSPINAL FLUID LEAKAGE OCCLUSION [patent_app_type] => utility [patent_app_number] => 16/085803 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9771 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/085803
CEREBROSPINAL FLUID LEAKAGE OCCLUSION Mar 16, 2017 Abandoned
Array ( [id] => 18153084 [patent_doc_number] => 11566045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Tumor targeting polypeptide and method of use thereof [patent_app_type] => utility [patent_app_number] => 15/562722 [patent_app_country] => US [patent_app_date] => 2017-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9976 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562722 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562722
Tumor targeting polypeptide and method of use thereof Mar 13, 2017 Issued
Array ( [id] => 16288803 [patent_doc_number] => 10765625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => Knottin-drug conjugates and methods of using the same [patent_app_type] => utility [patent_app_number] => 15/458852 [patent_app_country] => US [patent_app_date] => 2017-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 12562 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458852 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/458852
Knottin-drug conjugates and methods of using the same Mar 13, 2017 Issued
Array ( [id] => 12023645 [patent_doc_number] => 20170313745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 15/455508 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52232 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455508 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/455508
INHIBITORS OF HEPATITIS C VIRUS Mar 9, 2017 Abandoned
Array ( [id] => 16042935 [patent_doc_number] => 10683326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-16 [patent_title] => Crystalline salt forms [patent_app_type] => utility [patent_app_number] => 16/084168 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 25022 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084168 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/084168
Crystalline salt forms Mar 9, 2017 Issued
Menu